Value Sense
SNN
Smith & Nephew plc (SNN)
Last Price$29.80.3%
Market Cap$13.0B
LTM PEG 1Y
0.1x
5Y avg
0.0x
Medical - Devices industry median
0.1x
Stock quality & Intrinsic value
6/10
1.3% undervalued
SNN
is 132.9% undervalued
learn more -->
50+
undervalued stocks
Start beating the S&P 500

Smith & Nephew plc PEG 1Y

Annual
Quarterly
Daily
Crunching data... Almost there!
Dec'05Dec'06Dec'07Dec'08Dec'09Dec'10Dec'11Dec'12Dec'13Dec'14Dec'15Dec'16Dec'17Dec'18Dec'19Dec'20Dec'21Dec'22Dec'23Dec'24
PEG 1Y
0.1x
0.0x
0.0x
0.0x
0.1x
0.0x
0.0x
0.0x
0.0x
0.0x
0.0x
0.1x
0.0x
0.0x
0.0x
0.1x
0.1x
0.0x
0.1x
0.1x
SNN
Key metrics and insights to make informed decisions.
View full analysis
Overvalued or undervalued?
Check the intrinsic value for SNN and see if it's the right time to invest.
Dive in

Smith & Nephew plc (SNN) PEG 1Y comparison analysis

General

LTM PEG 1Y

OTHER METRICS

Company name

Revenue growth

EPS growth

Net Income margin

Smith & Nephew plc logo
Smith & Nephew plcSNN
0.1x
4.7%
(21.7%)
7.1%
Median Peer Set
0.3x
4.2%
59.2%
12.5%
DexCom, Inc. logo
DexCom, Inc.DXCM
1.1x
11.3%
(1.4%)
14.3%
Stryker Corporation logo
Stryker CorporationSYK
0.7x
10.2%
(5.8%)
13.2%
Boston Scientific Corporation logo
Boston Scientific CorporationBSX
0.6x
17.6%
16.7%
11.1%
STERIS plc logo
STERIS plcSTE
0.4x
3.6%
257.9%
7.4%
Medtronic plc logo
Medtronic plcMDT
0.3x
3.6%
(2.1%)
11.4%
Zimmer Biomet Holdings, Inc. logo
Zimmer Biomet Holdings, Inc.ZBH
0.3x
3.8%
(9.4%)
11.8%
Koninklijke Philips N.V. logo
Koninklijke Philips N.V.PHG
0.1x
(0.8%)
122.5%
(3.9%)
Edwards Lifesciences Corporation logo
Edwards Lifesciences CorporationEW
(0.1x)
(9.4%)
202.2%
76.7%
Abbott Laboratories logo
Abbott LaboratoriesABT
(0.5x)
4.6%
134.5%
31.9%
Insulet Corporation logo
Insulet CorporationPODD
(1.4x)
22.1%
101.7%
20.2%

SNN key stats

USD
Millions
Billions
Annual
Quarterly
Trailing
Key stats
Income statement
Balance sheet
Cash Flow Statement
Valuation
Ratios
Per share
Per employee
Dividends & Yields
Dec'05Dec'06Dec'07Dec'08Dec'09Dec'10Dec'11Dec'12Dec'13Dec'14Dec'15Dec'16Dec'17Dec'18Dec'19Dec'20Dec'21Dec'22Dec'23Dec'24
Revenue
% growth
2,552.0
6.6%
2,779.0
8.9%
3,369.0
21.2%
3,801.0
12.8%
3,772.0
(0.8%)
3,962.0
5.0%
4,270.0
7.8%
4,137.0
(3.1%)
4,351.0
5.2%
4,617.0
6.1%
4,634.0
0.4%
4,669.0
0.8%
4,765.0
2.1%
4,904.0
2.9%
5,138.0
4.8%
4,560.0
(11.2%)
5,212.0
14.3%
5,215.0
0.1%
5,549.0
6.4%
5,810.0
4.7%
Cost of Goods Sold (COGS)701.0769.0994.01,077.01,030.01,031.01,140.01,070.01,100.01,162.01,143.01,272.01,248.01,298.01,338.01,396.01,543.01,540.01,730.01,764.0
Gross Profit
% margin
1,851.0
72.5%
2,010.0
72.3%
2,375.0
70.5%
2,724.0
71.7%
2,742.0
72.7%
2,931.0
74.0%
3,130.0
73.3%
3,067.0
74.1%
3,251.0
74.7%
3,455.0
74.8%
3,491.0
75.3%
3,397.0
72.8%
3,517.0
73.8%
3,606.0
73.5%
3,800.0
74.0%
3,164.0
69.4%
3,669.0
70.4%
3,675.0
70.5%
3,819.0
68.8%
4,046.0
69.6%
Operating Expenses1,345.01,453.01,766.02,080.02,019.02,011.02,268.02,221.02,441.02,706.02,863.02,596.02,583.02,743.02,985.02,869.03,076.03,225.03,394.03,389.0
Research & Development Expenses (R&D)122.0120.0142.0152.0155.0151.0167.0171.0231.0235.0222.0230.0223.0246.0292.0307.0356.0345.0299.0289.0
Selling, General & Administrative Expenses (SG&A)1,212.01,319.01,530.01,796.01,864.01,860.02,101.02,050.02,210.02,471.02,641.02,366.02,360.02,497.02,693.02,562.02,720.02,880.02,890.03,100.0
Operating Income
% margin
422.0
16.5%
537.0
19.3%
493.0
14.6%
630.0
16.6%
723.0
19.2%
920.0
23.2%
862.0
20.2%
846.0
20.4%
810.0
18.6%
749.0
16.2%
628.0
13.6%
801.0
17.2%
934.0
19.6%
863.0
17.6%
815.0
15.9%
295.0
6.5%
593.0
11.4%
315.0
6.0%
425.0
7.7%
657.0
11.3%
Interest Income27.019.010.05.02.03.04.011.014.013.011.06.06.08.010.06.06.014.034.00.0
Interest Expense18.09.040.071.042.018.012.09.010.035.049.052.057.059.065.062.080.080.0139.00.0
Pre-tax Income428.0550.0469.0564.0670.0895.0848.01,100.0802.0714.0559.01,062.0879.0781.0743.0246.0586.0235.0290.0498.0
Income Tax
% effective tax rate
126.0
29.4%
156.0
28.4%
153.0
32.6%
187.0
33.2%
198.0
29.6%
280.0
31.3%
266.0
31.4%
371.0
33.7%
246.0
30.7%
213.0
29.8%
149.0
26.7%
278.0
26.2%
112.0
12.7%
118.0
15.1%
143.0
19.2%
(202.0)
(82.1%)
62.0
10.6%
12.0
5.1%
27.0
9.3%
86.0
17.3%
Net Income
% margin
333.0
13.0%
745.0
26.8%
316.0
9.4%
377.0
9.9%
472.0
12.5%
615.0
15.5%
582.0
13.6%
729.0
17.6%
556.0
12.8%
501.0
10.9%
410.0
8.8%
784.0
16.8%
767.0
16.1%
663.0
13.5%
600.0
11.7%
448.0
9.8%
524.0
10.1%
223.0
4.3%
263.0
4.7%
412.0
7.1%
EPS0.360.790.340.430.530.690.650.810.620.560.460.880.880.760.690.510.600.250.600.47
Diluted EPS0.350.790.340.420.530.690.650.810.610.560.460.880.880.760.680.510.600.250.600.47
EBITDA
% margin
683.0
26.8%
703.0
25.3%
721.0
21.4%
910.0
23.9%
1,039.0
27.5%
1,211.0
30.6%
1,164.0
27.3%
1,182.0
28.6%
1,184.0
27.2%
1,186.0
25.7%
1,115.0
24.1%
1,266.0
27.1%
1,393.0
29.2%
1,287.0
26.2%
1,320.0
25.7%
866.0
19.0%
1,242.0
23.8%
943.0
18.1%
979.0
17.6%
1,237.0
21.3%

Discover more Stock Ideas

Undervalued stocks right now

Undervalued stocks right now

Discover the top 20 best undervalued stocks to buy for Mar 2025, listed on the Nasdaq or NYSE.

3M Return 32.1%
S&P Outperformance 19.1%
Next 3M Predicted Return 20.3%
Undervalued growth stocks

Undervalued growth stocks

Discover the top 20 best undervalued large-cap growth stocks to buy for Mar 2025, listed on the Nasdaq or NYSE.

3M Return 35.3%
S&P Outperformance 22.3%
Next 3M Predicted Return 26.8%
Undervalued dividend stocks

Undervalued dividend stocks

Discover the top 20 best undervalued high-yield dividend stock that offers both growth potential and attractive dividend returns for Mar 2025.

3M Return 28.4%
S&P Outperformance 15.4%
Next 3M Predicted Return 16.9%
More ideas -->

FAQ

1) What is Smith & Nephew plc's PEG 1Y?

As of today, Microsoft Corp's last 12-month PEG 1Y is 0.1x, based on the financial report for Dec 30, 2024 (Q4’2024). The average annual PEG 1Y for Smith & Nephew plc have been 0.0x over the past three years, and 0.1x over the past five years.

2) Is Smith & Nephew plc's PEG 1Y Good?

As of today, Smith & Nephew plc's PEG 1Y is 0.1x, which is higher than industry median of 0.1x. It indicates that Smith & Nephew plc's PEG 1Y is Bad.

3) How does Smith & Nephew plc's PEG 1Y compare to its peers?

As of today, Smith & Nephew plc's PEG 1Y is 0.1x, which is lower than peer median of 0.3x. The list of peers includes DXCM, SYK, BSX, STE, MDT, ZBH, PHG, EW, ABT, PODD.